These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 2418160)

  • 1. Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.
    Carter WA; Hubbell HR; Krueger LJ; Strayer DR
    J Biol Response Mod; 1985 Dec; 4(6):613-20. PubMed ID: 2418160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies with Ampligen (mismatched double-stranded RNA).
    Carter WA; Strayer DR; Hubbell HR; Brodsky I
    J Biol Response Mod; 1985 Oct; 4(5):495-502. PubMed ID: 4078595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
    Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
    J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
    Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
    Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies with ampligen (mismatched double-stranded RNA).
    Brodsky I; Strayer DR; Krueger LJ; Carter WA
    J Biol Response Mod; 1985 Dec; 4(6):669-75. PubMed ID: 4087035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
    Dick RS; Hubbell HR
    J Neurooncol; 1987; 5(4):331-8. PubMed ID: 2450181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antiproliferative effect of human interferons in combination with mismatched double-stranded RNA on human tumor cells.
    Hubbell HR
    Int J Cancer; 1986 Mar; 37(3):359-65. PubMed ID: 2419265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.
    Hubbell HR; Kvalnes-Krick K; Carter WA; Strayer DR
    Cancer Res; 1985 Jun; 45(6):2481-6. PubMed ID: 3986788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assay.
    Strayer DR; Watson P; Carter WA; Brodsky I
    J Interferon Res; 1986 Aug; 6(4):373-9. PubMed ID: 3772178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
    Hubbell HR; Liu RS; Maxwell BL
    Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
    Sidky YA; Borden EC
    Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
    Hubbell HR; Boyer JE; Roane P; Burch RM
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):906-10. PubMed ID: 1846967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K; Tsukamoto T
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons.
    Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW
    Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of Ampligen.
    Brodsky I; Strayer DR
    Am Fam Physician; 1987 Oct; 36(4):253-6. PubMed ID: 3673869
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferons in the treatment of solid tumors. A general review].
    Dorval T; Pouillart P
    Bull Cancer; 1988; 75(9):885-8. PubMed ID: 2462946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.